IP Library Granted Patent US 10,221,390
Granted Patent B2
US 10,221,390 · App. 15/452,710 · Granted Mar 5, 2019

Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells

Inventors: Christopher Bankole Shogbon (Corning, NY); Yue Zhou (Horseheads, NY); Ralph Brandenberger (Palo Alto, CA)
Assignee: Asterias Biotherapeutics, Inc.
C12N5/0623C12M23/12C12N5/0068C12N5/0622C12N2500/90C12N2506/02C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,221,390
App. No.
15/452,710
Granted
Mar 5, 2019
Kind
B2
Abstract

Synthetic surfaces suitable for culturing stem cell derived oligodendrocyte progenitor cells contain acrylate polymers formed from one or more acrylate monomers. The acrylate surfaces, in many cases, are suitable for culturing stem cell derived oligodendrocyte progenitor cells in chemically defined media.

Claims (8)

1. A method for culturing human pluripotent stem cell-derived oligodendrocyte progenitor cells, comprising depositing a suspension comprising the human pluripotent stem cell-derived oligodendrocyte progenitor cells on a polymer material, and culturing the deposited human pluripotent stem cell-derived oligodendrocyte progenitor cells in a cell culture medium, wherein the polymer material comprises a diacrylate or a dimethacrylate.

2. The method of claim 1 , wherein the dimethacrylate is glycerol dimethacrylate.

3. The method of claim 1 , wherein the diacrylate is 1,6-hexanediol diacrylate.

4. The method of claim 1 , wherein the diacrylate is tetra(ethylene glycol) diacrylate.

5. The method of claim 1 , wherein the polymer material comprises about 70% glycerol dimethacrylate.

6. The method of claim 1 , wherein the human pluripotent stem cells are human sells induced pluripotent stem (iPS) cells.

7. The method of claim 1 , wherein the human pluripotent stem cells are human embryonic stem (hES) cells.

8. The method of claim 1 , wherein the cell culture medium is a chemically defined medium.

Continuity (5)
Continuation 14997999 · Jan 18, 2016
Continuation 13946032 · Jul 19, 2013
Continuation 12362250 · Jan 29, 2009
Provisional Application 61063010 · Jan 30, 2008
Related Publication 20180023053A1 · Jan 25, 2018